1Current status of immunodepressants in heart transplantationDU Juan, HUANG Jie, HU Sheng-shou1137-11402The clinical application and mechanisms evolution of thalidomide and its derivativesCHEN Li-hui, LI Dian-dong1141-11453Strategies for safety evaluation of drug metabolitesLU Guo-cai, YUAN Bo-jun1145-11484New nanoparticle delivery system: nanostructured lipid carriersHUANG Ya-qin, TIAN Zhi-ke, PAN Yi-bin, HOU Guo-zhi1149-11525Quantitative description of drug oral absorption in human on the basis of its studyWANG Hong, GUO Dai-hong, QI Xue-zhen1152-11566Affinity and selectivity of compound Ⅲ-21, a novel nonpeptide endothelin antagonist for rat ETA and ETB receptorsXIA Hui-jing, DAI De-zai, JI Min, WANG Shu-kui, DU Tong-xin, TANG Xiao-yun1157-11607Effect of escitalopram on behavior and plasma CORT and ACTH in chronic stress depression ratsZHOU Jie, ZHANG Dong-qi, SUN Li-sha, LI Xue, LIN Huan-bing, XU Jiang-ping1160-11638Protective effects of Danshen powders for injection on myocardium ischemia/reperfusion injury in ratsZHAO Lei, PU Xiao-ping1164-11669Safety evaluation of arbidol in animalsCHEN Qi-you, ZHOU Yi-ping, CHEN Si-yan, YANG Jing-hua1166-116910Protective effect of blood active peptide extracts on hypoxic myocardiumLI Dong-li, YU Hong-ru, YANG Jing, WANG Hong-xin, LIANG Wei-wei, ZHANG Ting1169-117211Preparation of metoprolol tartrate sustained-release pelletsHUANG Jian, GAO Chun-sheng, SHAN Li, MEI Xing-guo1172-117612Preparation and characteristics of liposomal retinoic acidCAI Ming-zhi, HUANG Fu-sheng, WANG Kun1181-118313Lovastatin osmotic pump tablets:preparation and drug release behaviors in vitroCHEN Kai, L(U) Zi-ming, PAN Wei-san, NIE Shu-fang1183-118714Synthesis of moracizine hydrochlorideWANG Shao-jie, HAO Dong, CHEN Xin, YANG Zhuo1188-119015Quantification of ranolzaine and its relevant substances by RP-HPLCYE Ya-lin, YANG Xue-mei, XUN Da, XU Jiang-ping1190-119216Determination of residual organic solvents in aceclofenac by GCCHEN Li-sheng, YANG Jing-hua, ZHOU Zu-kun1193-119417Efficacy and safety of enalapril/HCTZ compounds versus Enalapril alone in Chinese subjects with primary hypertensionHUA Lu, LI Yi-shi, MING Guang-hua, KE Yuan-nan, GUO Ji-zhen, FAN Wei-hu, WU Zong-gui, HUANG Jie, WANG Fang, KANG Lian-ming, LI Wei, GONG Pei1195-119818Safety and efficacy of telmisartan for the treatment of essential hypertensionGONG Hong-tao, DU Feng-he1199-120119Clinical evaluation of atorvastatin in the improvement of plasma Fib levels in patients with acute coronary syndromesZHANG Yun, LI Yin-rong, SUN Ze-gang, XIONG Pan, LIU Fang1201-120320Efficacy of propylgallate combined with low molecular weight heparin sodium for the treatment of acute cerebral infarctionYANG Xia-feng, SUN Yi-hua, XU Jun, LI Yan-hui, WANG Feng-yun, LIU Jia1203-1205 